GeneralBullishCrypto Briefing · 4h ago6/10
📰
NewLimit triples valuation to $3B with $435M funding round
NewLimit, a biotech company focused on aging research, has tripled its valuation to $3 billion in a $435 million funding round. The funding surge reflects investor optimism about biotech's potential to address aging, despite significant clinical and regulatory uncertainties that remain.
